Influence of Vitamin D Deficiency on the Development of Autism
1 other identifier
observational
300
1 country
1
Brief Summary
The investigators wish to study the effect of Vitamin D on the development of autism in children. The investigators will also investigate the environmental and genetic influences on the level of Vitamin D in children with autism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2014
CompletedFirst Posted
Study publicly available on registry
August 21, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedAugust 21, 2014
August 1, 2014
3 years
August 11, 2014
August 20, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Level of Vitamin D
Blood samples of patients with and without autism with be taken and the level of vitamin D in their serum will be determined (international units).
One day
Secondary Outcomes (1)
Effect of environment on Vitamin D level
One week
Study Arms (3)
Autistic Children
Children diagnosed with autism spectrum disorder according to the criteria of the Diagnostic Statistical Manual-V will have blood samples taken for laboratory analysis.
Healthy Children
Children with no developmental or physical diseases will have blood samples taken for laboratory analysis.
Children with Attention Deficit Disorder
Blood samples from children with Attention Deficit Disorder will be measured for Vitamin D and oxidative stress markers.
Interventions
Eligibility Criteria
Children with autism who have presented to the Child Development Institute at the Hillel Yaffe Medical Center and from pediatric neurology community clinics. The control groups include healthy age-matched children and children with Attention Deficit Disorder (ADD) who have presented to the Child Development Institute at the Hillel Yaffe Medical Center and from pediatric neurology community clinics.
You may qualify if:
- Autistic children
- Healthy children
- Children with ADD
You may not qualify if:
- All others
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hillel Yaffe Medical Center
Hadera, 38100, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2014
First Posted
August 21, 2014
Study Start
November 1, 2014
Primary Completion
November 1, 2017
Study Completion
April 1, 2018
Last Updated
August 21, 2014
Record last verified: 2014-08